3 news items
Why Signet Jewelers Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
AMSC
AVGO
BITF
13 Jun 24
study evaluating the efficacy and safety of oral difelikefalin for moderate-to-severe pruritus in adult patients with notalgia paresthetica. Also
Why GLP-1 Developer Vivani Medical's Stock Is Climbing
VANI
13 Jun 24
clinical trial to assess the safety, tolerability and pharmacokinetics of NPM-119, the company’s miniature, six-month GLP-1 implant in development
EXCLUSIVE: Vivani Medical's Type 2 Diabetes Treatment NPM-119 Subdermal Implant's IND Gains FDA Clearance For Clinical Use (UPDATED)
VANI
13 Jun 24
.
This study will assess the safety, tolerability, and pharmacokinetics of Vivani’s innovative six-month GLP-1 implant, designed to treat type 2
- Prev
- 1
- Next